Cargando…
Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer
Demethoxycurcumin (DMC), through a self-assembled amphiphilic carbomethyl-hexanoyl chitosan (CHC) nanomatrix has been successfully developed and used as a therapeutic approach to inhibit cisplatin-induced drug resistance by suppressing excision repair cross-complementary 1 (ERCC1) in non-small cell...
Autores principales: | Chen, Ying-Yi, Lin, Yu-Jung, Huang, Wei-Ting, Hung, Chin-Chuan, Lin, Hui-Yi, Tu, Yu-Chen, Liu, Dean-Mo, Lan, Shou-Jen, Sheu, Ming-Jyh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320861/ https://www.ncbi.nlm.nih.gov/pubmed/30563166 http://dx.doi.org/10.3390/molecules23123217 |
Ejemplares similares
-
ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin
por: Chen, Long, et al.
Publicado: (2017) -
Demethoxycurcumin Preserves Renovascular Function by Downregulating COX-2 Expression in Hypertension
por: Li, Yingjuan, et al.
Publicado: (2016) -
Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway
por: Chen, Yun, et al.
Publicado: (2020) -
Effects of demethoxycurcumin on the viability and apoptosis of skin cancer cells
por: Wu, Yaoqun, et al.
Publicado: (2017) -
Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice In Vivo
por: Huang, Yi-Ping, et al.
Publicado: (2021)